All Insights Case Study Creating A COVID-19 Immune Incentive Compensation Plan

    Creating A COVID-19 Immune Incentive Compensation Plan

    Incentive Compensation

    Creating A COVID-19 Immune Incentive Compensation Plan

    A multifold approach towards the “new normal” to ensure fair and motivating compensation plans.

    Download Case Study
    Creating A COVID-19 Immune Incentive Compensation Plan

    With COVID-19-imposed nationwide lockdowns, weak field productivity, and detailing restrictions, the pandemic is directly impacting the Incentive Compensation (IC) of reps across the pharma industry. Companies also continue to struggle to alleviate the sales teams’ health and monetary fears. A right incentive strategy can motivate sales reps and provide a sense of financial security.

    With this solution, the client benefited from:
    Plan Score

    A robust IC program to withstand the business fluctuations imposed by the pandemic.

    Rx-Revenue-icon-3

    The continuous motivation for sales reps with balanced pay outs and exciting rewards.

    Rx-1

    Insulation from market variations and different geographic behavior through the COVID-19 impacted period.

    Read this illustration to know about Axtria’s multi-fold approach towards creating a COVID-19 immune incentive compensation plan for a pharma company.

    Download the free case study here.

    Contact us at insights@axtria.com with any questions.

    Learn More linkClick Here To Learn More About Axtria Incentive Compensation Benchmarking Study – 2020 Results

    Complete the brief form to download the white paper

    Recommended insights

    Covid-19 Immune Incentive Compensation Plan Case Study

    White Paper

    Orchestrating Omnichannel Measurement Approaches for Enabling Outcomes-Driven, Personalized Campaigns

    Covid-19 Immune Incentive Compensation Plan Case Study

    Report

    2023 Alignment Design and Refinement Benchmarking Study

    Covid-19 Immune Incentive Compensation Plan Case Study

    Report

    2023 Global (Ex-US) Incentive Compensation Benchmarking Study